Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · IEX Real-Time Price · USD
10.16
-0.38 (-3.65%)
Apr 25, 2024, 12:35 PM EDT - Market open
Amicus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 246.99 | 148.81 | 245.2 | 163.24 | 142.84 | 79.75 | 49.06 | 187.03 | 69.49 | 24.07 | Upgrade
|
| Short-Term Investments | 39.21 | 144.78 | 237.3 | 320.03 | 309.9 | 424.4 | 309.5 | 143.33 | 144.55 | 127.6 | Upgrade
|
| Cash & Cash Equivalents | 286.2 | 293.6 | 482.5 | 483.27 | 452.74 | 504.15 | 358.56 | 330.35 | 214.03 | 151.68 | Upgrade
|
| Cash Growth | -2.52% | -39.15% | -0.16% | 6.74% | -10.20% | 40.60% | 8.54% | 54.35% | 41.11% | 84.97% | Upgrade
|
| Receivables | 87.63 | 66.2 | 52.67 | 46.92 | 33.28 | 21.96 | 9.46 | 1.3 | 0 | 0 | Upgrade
|
| Inventory | 59.7 | 23.82 | 26.82 | 19.56 | 14.04 | 8.39 | 4.62 | 3.42 | 0 | 0 | Upgrade
|
| Other Current Assets | 49.53 | 40.21 | 34.85 | 29.72 | 20.01 | 16.59 | 19.32 | 4.99 | 2.57 | 2.9 | Upgrade
|
| Total Current Assets | 483.06 | 423.82 | 596.83 | 579.47 | 520.07 | 551.1 | 391.97 | 340.06 | 216.6 | 154.58 | Upgrade
|
| Property, Plant & Equipment | 57.98 | 60.31 | 63.08 | 67.16 | 81.02 | 11.38 | 9.06 | 9.82 | 6.18 | 2.81 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.46 | Upgrade
|
| Goodwill and Intangibles | 218.29 | 220.8 | 197.8 | 197.8 | 197.8 | 197.8 | 197.8 | 197.8 | 197.8 | 11.61 | Upgrade
|
| Other Long-Term Assets | 18.55 | 19.24 | 47.43 | 42.1 | 51.32 | 29.68 | 28.2 | 489.17 | 487.81 | 23.5 | Upgrade
|
| Total Long-Term Assets | 294.82 | 300.35 | 308.31 | 307.05 | 330.13 | 238.86 | 235.06 | 696.78 | 691.78 | 55.39 | Upgrade
|
| Total Assets | 777.88 | 724.17 | 905.14 | 886.52 | 850.21 | 789.95 | 627.02 | 1,037 | 908.38 | 209.97 | Upgrade
|
| Accounts Payable | 15.12 | 36.83 | 40.41 | 42.89 | 44.4 | 100.33 | 79.29 | 254.63 | 306.49 | 27.05 | Upgrade
|
| Current Debt | 8.32 | 8.55 | 7.41 | 6.87 | 7.19 | 0 | 0 | 0 | 0 | 3.84 | Upgrade
|
| Other Current Liabilities | 144.25 | 93.64 | 98.15 | 79.92 | 77.22 | -14.2 | -9.25 | -143.67 | -232.88 | -10.7 | Upgrade
|
| Total Current Liabilities | 167.69 | 139.02 | 145.98 | 129.68 | 128.81 | 86.13 | 70.04 | 110.96 | 73.62 | 20.19 | Upgrade
|
| Long-Term Debt | 436.74 | 443.57 | 432.72 | 434.86 | 203.04 | 321.74 | 164.17 | 154.46 | 0 | 10.51 | Upgrade
|
| Other Long-Term Liabilities | 13.28 | 18.53 | 19.08 | 35.61 | 41.93 | 39.17 | 39.97 | 411.27 | 486.93 | 57.09 | Upgrade
|
| Total Long-Term Liabilities | 450.02 | 462.1 | 451.8 | 470.46 | 244.97 | 360.91 | 204.13 | 565.74 | 486.93 | 67.6 | Upgrade
|
| Total Liabilities | 617.71 | 601.12 | 597.77 | 600.14 | 373.78 | 447.04 | 274.17 | 676.69 | 560.55 | 87.79 | Upgrade
|
| Total Debt | 445.06 | 452.12 | 440.13 | 441.73 | 210.23 | 321.74 | 164.17 | 154.46 | 0 | 14.35 | Upgrade
|
| Debt Growth | -1.56% | 2.72% | -0.36% | 110.12% | -34.66% | 95.98% | 6.28% | - | - | -0.85% | Upgrade
|
| Retained Earnings | -2,684.07 | -2,532.49 | -2,295.92 | -2,045.46 | -1,768.61 | -1,412.22 | -1,063.61 | -779.61 | -579.57 | -447.45 | Upgrade
|
| Comprehensive Income | 5.24 | -12.11 | 4.98 | 8.23 | 2.83 | 0.07 | -2.1 | 2.05 | -0.12 | -0.13 | Upgrade
|
| Shareholders' Equity | 160.17 | 123.05 | 307.37 | 286.38 | 476.43 | 342.91 | 352.85 | 360.15 | 347.83 | 122.18 | Upgrade
|
| Net Cash / Debt | -158.86 | -158.53 | 42.37 | 41.54 | 242.52 | 182.41 | 194.4 | 175.89 | 214.03 | 137.33 | Upgrade
|
| Net Cash / Debt Growth | - | - | 1.99% | -82.87% | 32.95% | -6.16% | 10.52% | -17.82% | 55.86% | 103.36% | Upgrade
|
| Net Cash Per Share | -0.54 | -0.55 | 0.16 | 0.16 | 1.01 | 0.98 | 1.27 | 1.31 | 1.95 | 1.84 | Upgrade
|
| Working Capital | 315.37 | 284.8 | 450.86 | 449.79 | 391.26 | 464.97 | 321.93 | 229.11 | 142.99 | 134.39 | Upgrade
|
| Book Value Per Share | 0.54 | 0.43 | 1.13 | 1.11 | 1.98 | 1.85 | 2.30 | 2.68 | 3.16 | 1.64 | Upgrade
|